UnknownPhase 3NCT00454168
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Vaccine Company
- Principal Investigator
- Craig S. Rosenfeld, MD, MDThe Vaccine Company
- Intervention
- PR1 leukemia peptide vaccine(biological)
- Enrollment
- 244 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2005
Study locations (15)
- Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
- Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
- Vaccine Company, South San Francisco, California, United States
- Rush Cancer Institute at Rush University Medical Center, Chicago, Illinois, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
- St. Francis Hospital Cancer Care Services, Indianapolis, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, United States
- Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
- Case Comprehensive Cancer Center, Cleveland, Ohio, United States
- UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States
- Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
- Cancer Care Centers of South Texas - Southeast, San Antonio, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00454168 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.